Yixintang Pharmaceutical Group Co (SZSE:002727) Accounts Payable & Accrued Expense : ¥6,111 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co Accounts Payable & Accrued Expense?

Yixintang Pharmaceutical Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥5,031 Mil) to Dec. 2023 (¥5,499 Mil) and increased from Dec. 2023 (¥5,499 Mil) to Mar. 2024 (¥6,111 Mil).

Yixintang Pharmaceutical Group Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥4,631 Mil) to Dec. 2022 (¥5,351 Mil) and increased from Dec. 2022 (¥5,351 Mil) to Dec. 2023 (¥5,499 Mil).

Yixintang Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

Yixintang Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,752.32

3,403.72

4,631.34

5,351.10

5,499.28

Yixintang Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,349.35	4,790.05	5,030.88	5,499.28	6,110.69

Yixintang Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500

Website

http://www.hx8886.com

Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.

Executives

Zhang Yong	Directors, executives
Xiao Dong Lei	Executives
Liu Qiong	Director
Ruan Hong Xian	Directors, executives
Guo Chun Li	Director
Ruan Guo Wei	Directors, executives
Li Zheng Hong	Directors, executives
Zhao Biao	Directors, executives
Tian Jun	Directors, Directors, and Executives
Xu Ke Yi	Director
Luo Yong Bin	Executives
Zhou Hong Yun	Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines